Sun Pharmaceutical Industries Limited — Others, 13-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Sun Pharmaceutical Industries Limited has submitted a confirmation certificate from MUFG Intime India Pvt. Ltd. for the quarter ended December 31, 2024. This document verifies that securities received for dematerialization were processed appropriately and remain compliant with listing requirements on stock exchanges. The company reports no requests for rematerialization during this period. This update reinforces operational efficiency in handling share transfers, contributing to a smoother process for shareholders. Investor sentiment could lean positively, as such confirmations often signal robust governance and a commitment to transparency, key factors for long-term value.